Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-15-061195
Filing Date
2015-10-28
Accepted
2015-10-28 15:11:22
Documents
5
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v423016_10ka.htm 10-K/A 355279
2 EXHIBIT 31.1 v423016_ex31-1.htm EX-31.1 9604
3 EXHIBIT 31.2 v423016_ex31-2.htm EX-31.2 9797
4 EXHIBIT 32.1 v423016_ex32-1.htm EX-32.1 4237
5 EXHIBIT 32.2 v423016_ex32-2.htm EX-32.2 4557
  Complete submission text file 0001144204-15-061195.txt   384698
Mailing Address 4045 SORRENTO VALLEY BOULEVARD SAN DIEGO CA 92121
Business Address 4045 SORRENTO VALLEY BOULEVARD SAN DIEGO CA 92121 908-864-4444
Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-31326 | Film No.: 151180059
SIC: 8731 Services-Commercial Physical & Biological Research